Allchem Lifescience Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Allchem Lifescience Limited's is preparing to launch its Initial Public Offering (IPO) with a substantial issue size of TBD. The offering comprises a fresh issue component of TBD.
The price band for the IPO has been set at TBD, providing investors with a range to place their bids. The minimum investment lot consists of TBD, making it accessible to both retail and institutional investors.
The subscription window for this public offering opens on TBD and will conclude on TBD. Following the subscription period, the share allotment is scheduled for TBD, with the official listing expected to commence on TBD on the NSE, BSE exchange.
Founded in 2017, Allchem Lifescience Limited is a pharmaceutical and specialty chemical manufacturing company that produces active pharmaceutical ingredient (API) intermediates, key starting materials, and fine chemicals used in drug production. It operates through two main segments: API intermediates, which are essential building blocks for making medicines, and specialty chemicals designed for specific industrial applications. The company has developed the capability to manufacture over 260 different products, serving both Indian and international pharmaceutical and chemical companies. Its customers include well-known pharma firms in India and abroad, supporting a wide global client base. The company’s manufacturing facility is located in Vadodara, Gujarat, with a significant production capacity, and as of December 31, 2024, it had around 430 permanent employees.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
The expected premium (GMP) is based on market buzz and unofficial trading. It should not be considered as the guaranteed listing price. Always refer to the RHP and seek advice from a financial expert before making investment decisions.
💡 Read our detailed guide: What is IPO Grey Market Premium (GMP) & How It Works?•📈 Track all live rates on IPO GMP Today
- Specialty Chemical Manufacturing: Company pharma intermediates ane fine chemicals banave che, je high-value niche segment ma aave che.
- Pharma Industry Demand Linkage: Pharmaceutical sector ma consistent demand hova thi stable long-term growth support male che.
- Export-Oriented Business: International markets ma presence hova thi revenue diversification ane global demand exposure male che.
- Raw Material Price Risk: Chemical inputs ni price volatility thi cost ane profitability par direct asar pade che.
- Regulatory Compliance Burden: Pharma-chemical industry ma strict safety ane environmental norms hoy, je operational cost vadhaare che.
- Small Scale Limitation: Company nu size relatively nanu hoy to large global players sathe competition challenging bani shake che.
- Bipin Patel
- Manisha Bipin Patel
- Kantilal Ramanlal Patel
- Aditi Patel
Allchem Lifescience Limited
Link Intime India Private Limited